NEUTROPHIL FUNCTION AND OPIOID RECEPTOR EXPRESSION ON LEUCOCYTES DURING CHRONIC NALTREXONE TREATMENT IN HUMANS
- 31 August 1999
- journal article
- Published by Elsevier in Pharmacological Research
- Vol. 40 (2) , 153-158
- https://doi.org/10.1006/phrs.1999.0488
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Mechanism Involved in the Antiplatelet Activity of Naloxone in Human PlateletsBiochemical and Biophysical Research Communications, 1997
- Granulocyte defects and opioid receptors in chronic exposure to heroin or methadone in humansInternational Journal of Immunopharmacology, 1994
- Role of Increase of Opiod Receptors in Granulocyte CDllb/CD18 DysfunctionAnnals of the New York Academy of Sciences, 1993
- Evidence for an opioid inhibitory effect on T cell proliferationJournal of Neuroimmunology, 1993
- A stereoselective blockade by naloxone of opioid and non-opioid-induced granulocyte activationInternational Journal of Immunopharmacology, 1989
- Upregulation of opioid receptor subtypes correlates with potency changes of morphine and dadleLife Sciences, 1988
- Morphine and methadone impact on human phagocytic physiologyInternational Journal of Immunopharmacology, 1985
- Fluorescent probes for opioid receptorsLife Sciences, 1983
- Chronic naltrexone increases opiate binding in brain and produces supersensitivity to morphine in the locus coeruleus of the ratBrain Research, 1983
- LEUKOCYTE LOCOMOTION AND CHEMOTAXISThe Journal of Experimental Medicine, 1973